Omalizumab in the Treatment of Chronic Inducible Urticaria.
Sign Up to like & getrecommendations! Published in 2017 at "Actas dermo-sifiliograficas"
DOI: 10.1016/j.ad.2016.07.018
Abstract: Omalizumab is a recombinant humanized monoclonal antibody that inhibits immunoglobulin E. It has been approved for the treatment of severe asthma and chronic spontaneous urticaria refractory to other treatments. Its use in the management of… read more here.
Keywords: inducible urticaria; omalizumab treatment; treatment chronic; chronic inducible ... See more keywords
Analysis of the Efficacy and Recurrence of Omalizumab Use in the Treatment of Chronic Spontaneous Urticaria and Chronic Inducible Urticaria.
Sign Up to like & getrecommendations! Published in 2023 at "International archives of allergy and immunology"
DOI: 10.1159/000529250
Abstract: INTRODUCTION Chronic urticaria (CU) is a common skin condition that can be divided into chronic spontaneous urticaria (CSU) and chronic inducible urticaria (CIndU). Omalizumab is one treatment option for CU, but currently there are limited… read more here.
Keywords: spontaneous urticaria; chronic inducible; efficacy; treatment ... See more keywords